FDA Overrules Staff Analysis in Approving Anticlotting Drug-wsj.com

FDA Overrules Staff Analysis in Approving Anticlotting Drug-wsj.com: The Food and Drug Administration on Friday approved the latest in a class of new anticlotting drugs to prevent stroke—Xarelto from Johnson & Johnson and Bayer AG—but overruled its own staff's analysis in doing so.